LSTA
Price
$2.66
Change
+$0.06 (+2.31%)
Updated
Jun 4 closing price
Capitalization
22.87M
74 days until earnings call
NAGE
Price
$11.71
Change
-$0.00 (-0.00%)
Updated
Jun 5, 10:32 AM (EDT)
Capitalization
922.79M
62 days until earnings call
Interact to see
Advertisement

LSTA vs NAGE

Header iconLSTA vs NAGE Comparison
Open Charts LSTA vs NAGEBanner chart's image
Lisata Therapeutics
Price$2.66
Change+$0.06 (+2.31%)
Volume$8.61K
Capitalization22.87M
Niagen Bioscience
Price$11.71
Change-$0.00 (-0.00%)
Volume$2.31K
Capitalization922.79M
LSTA vs NAGE Comparison Chart
Loading...
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LSTA vs. NAGE commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSTA is a StrongBuy and NAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (LSTA: $2.66 vs. NAGE: $11.72)
Brand notoriety: LSTA and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LSTA: 61% vs. NAGE: 69%
Market capitalization -- LSTA: $22.87M vs. NAGE: $922.79M
LSTA [@Biotechnology] is valued at $22.87M. NAGE’s [@Biotechnology] market capitalization is $922.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $318.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LSTA’s FA Score shows that 1 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • LSTA’s FA Score: 1 green, 4 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, NAGE is a better buy in the long-term than LSTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LSTA’s TA Score shows that 5 TA indicator(s) are bullish while NAGE’s TA Score has 3 bullish TA indicator(s).

  • LSTA’s TA Score: 5 bullish, 4 bearish.
  • NAGE’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, LSTA is a better buy in the short-term than NAGE.

Price Growth

LSTA (@Biotechnology) experienced а -0.75% price change this week, while NAGE (@Biotechnology) price change was +10.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.56%. For the same industry, the average monthly price growth was +5.22%, and the average quarterly price growth was -1.09%.

Reported Earning Dates

LSTA is expected to report earnings on Aug 18, 2025.

NAGE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+6.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($923M) has a higher market cap than LSTA($22.9M). NAGE YTD gains are higher at: 120.829 vs. LSTA (-10.738). NAGE has higher annual earnings (EBITDA): 14.7M vs. LSTA (-22.24M). NAGE has more cash in the bank: 55.5M vs. LSTA (31.2M). LSTA has less debt than NAGE: LSTA (137K) vs NAGE (3.52M). NAGE has higher revenues than LSTA: NAGE (108M) vs LSTA (1M).
LSTANAGELSTA / NAGE
Capitalization22.9M923M2%
EBITDA-22.24M14.7M-151%
Gain YTD-10.738120.829-9%
P/E RatioN/A65.08-
Revenue1M108M1%
Total Cash31.2M55.5M56%
Total Debt137K3.52M4%
FUNDAMENTALS RATINGS
LSTA vs NAGE: Fundamental Ratings
LSTA
NAGE
OUTLOOK RATING
1..100
7725
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
83
Overvalued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9429
PRICE GROWTH RATING
1..100
5135
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LSTA's Valuation (23) in the null industry is somewhat better than the same rating for NAGE (83) in the Chemicals Specialty industry. This means that LSTA’s stock grew somewhat faster than NAGE’s over the last 12 months.

NAGE's Profit vs Risk Rating (69) in the Chemicals Specialty industry is in the same range as LSTA (100) in the null industry. This means that NAGE’s stock grew similarly to LSTA’s over the last 12 months.

NAGE's SMR Rating (29) in the Chemicals Specialty industry is somewhat better than the same rating for LSTA (94) in the null industry. This means that NAGE’s stock grew somewhat faster than LSTA’s over the last 12 months.

NAGE's Price Growth Rating (35) in the Chemicals Specialty industry is in the same range as LSTA (51) in the null industry. This means that NAGE’s stock grew similarly to LSTA’s over the last 12 months.

NAGE's P/E Growth Rating (99) in the Chemicals Specialty industry is in the same range as LSTA (100) in the null industry. This means that NAGE’s stock grew similarly to LSTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LSTANAGE
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
LSTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLRB0.460.18
+66.32%
Cellectar Biosciences
ARES169.010.48
+0.28%
Ares Management Corp
LOMA12.46-0.07
-0.56%
Loma Negra Compania Industrial Argentina Sociedad Anonima
WGS72.39-0.42
-0.58%
GeneDx Holdings Corp
APLE11.52-0.10
-0.86%
Apple Hospitality REIT

LSTA and

Correlation & Price change

A.I.dvisor tells us that LSTA and RAIN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LSTA and RAIN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LSTA
1D Price
Change %
LSTA100%
+2.18%
RAIN - LSTA
29%
Poorly correlated
+22.50%
ASND - LSTA
26%
Poorly correlated
-0.41%
GMAB - LSTA
26%
Poorly correlated
+2.01%
IMVT - LSTA
25%
Poorly correlated
-0.65%
MRUS - LSTA
25%
Poorly correlated
-7.75%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with AXON. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-0.55%
AXON - NAGE
43%
Loosely correlated
+2.76%
MDGL - NAGE
41%
Loosely correlated
-1.79%
ORMP - NAGE
35%
Loosely correlated
+0.88%
AMRN - NAGE
35%
Loosely correlated
-0.88%
CYTK - NAGE
35%
Loosely correlated
+1.28%
More